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Today, numerous nanotechnology-derived applications are commercially available. More than 1000
products are already available on the market [1, 2]. The use of nanoparticles (NPs) has increased in the
past few years in various ﬁelds including defence, aerospace, electronics, biology, and medicine. Therefore
as human exposure to NPs increases, so do investigations on their toxicity. In one hand, nanotoxicology
can be seen as an important subdiscipline of toxicology, and, on the other hand, it also represents a
subdiscipline of nanotechnology [3]. Studies show that many parameters such as the diameter, surface
area, surface composition, and solubility, to name a few, can all have an effect on cell responses, cellular
interactions, and reactive oxygen species (ROS) production. They can also have an effect on NP capacity to
bind to certain proteins or receptors. More importantly these parameters and others have also the potential
to inﬂuence an inﬂammatory response following NP exposure as it has been shown in many in vitro and in
vivo studies [4–7]. It has often been demonstrated that smaller particles tend to induce greater inﬂammatory
responses than their bigger counterparts of same chemical composition [5]. Although some NPs may
possess proinﬂammatory activities, the use of others and NP techniques can be very useful in medicine;
for example, they can be used for drug-delivery therapies and may also represent excellent biomarkers for
the diagnosis of diverse diseases, including inﬂammatory diseases.
In an effort to increase our general knowledge regarding the inﬂammatory properties of NPs, this
special issue of TheScientiﬁcWorldJOURNAL was planned in order to generate an important bibliographic
tool in this emerging area of research.
As the main organ in which the effect of NPs has been (and is still) addressed in the literature is the
lung, the ﬁrst paper from K.-I. Inoue and H. Takano provides insights into the immunotoxicity of airborne
and engineered NPs. It deals with the fact that such NPs act as an exacerbating factor on hyper susceptible
subjects with immune-mediated pulmonary inﬂammation. Interestingly, this review put the emphasis on
the fact that impairment of both innate and adaptive immunity following NP exposure may synergistically
facilitate pathological pulmonary inﬂammation.
The second article is a contribution from M. Roursgaard and collaborators that also focuses on
pulmonary inﬂammation, but by speciﬁcally investigating acute and subchronic airway inﬂammation
of quartz and Titanium dioxide (TiO2) agglomerates administered by intratracheal instillation in mice.
Inﬂammation was evaluated from the bronchoalveolar lavage ﬂuids content of inﬂammatory cells, the
cytokines TNF-α, and IL-6 as well as from lung histology. Using this approach, the inﬂammatory effects
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of two types of quartz (SRM1878a and DQ12) and the effects of different particle sizes and polymorphs of
TiO2 NPs were compared in this study.
The third paper from Stevenson and colleagues is a review that covers the usefulness of NPs in
medicine. They highlight the importance of using nanoparticle techniques in order to provide excellent
biomarkers for either the diagnosis of inﬂammatory diseases or their progression. They discuss the merit of
diverse approaches related to their possible application in inﬂammatory diseases.
The next paper conducted by M. Hayder and collaborators deals with the anti-inﬂammatory
properties of dendrimers. They discuss how these NPs are attractive nanotools for applications, especially
in biology and medicine. Interestingly, this review is based on the ﬁve main scientiﬁc articles dealing on the
anti-inﬂammatory properties displayed by dendrimers.
The ﬁfth article focuses on cumulative evidences observed by Y. Song and S. Tang in some
patients exposed to NPs who present an unusual inﬂammatory pulmonary disease based on several distinct
parameters. This paper conﬁrms the importance of doing further research and collaborative efforts on
nanosafety to prevent or, at least, minimize potential hazardous effects of NPs and nanomaterials to humans
and environment.
Positioning the importance of neutrophils in inﬂammation, the last review from D. M. Gonc ¸alves et
al. summarizes the current literature regarding the activation of these cells by NPs. It represents certainly
an important bibliographic tool for researchers interested in nanotoxiclogy or related ﬁelds, as well as in
inﬂammation and in general neutrophil cell biology.
In summary, this special issue of TheScientiﬁcWorldJOURNAL deals with two aspects on NPs and
inﬂammation that are not mutually exclusive: (1) the usefulness of NPs in general biology and medicine
and (2) the evaluation of safety for using NPs. Studying the effects of NPs on the inﬂammation process is
certainly a great step towards improving global knowledge about NPs in biology. Important discoveries will
certainly emerge in the becoming years in this area of research.
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